Latest News & Features
Big Pharma
Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system. 10 April 2019
Americas
The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical. 10 April 2019
Americas
Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn. 10 April 2019
Big Pharma
Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid. 9 April 2019
Americas
Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics. 9 April 2019
Americas
India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica. 8 April 2019
Americas
The US Food and Drug Administration and US Customs and Border Protection have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health. 5 April 2019
Americas
AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira. 4 April 2019
Medtech
Massachusetts-based Medrobotics has failed to convince the EU General Court that its trademark for ‘See More. Reach More. Treat More.’ should be registered. 4 April 2019
Biotechnology
The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape. 4 April 2019